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Dear Editor,
Neurological disorder is one of the greatest threats 
to public health according to the World Health Organi-
zation. Because neurons have little or no regenerative 
capacity, conventional therapies for neurological disor-
ders yielded poor outcomes. While the introduction of 
exogenous neural stem cells or neurons holds promise, 
many challenges still need to be tackled, including cell 
resource, delivery strategy, cell integration and cell 
maturation. Reprogramming of fibroblasts into induced 
pluripotent stem cells or directly into desirable neuronal 
cells by transcription factors (TFs) or small molecules 
can solve some problems, but other issues remain to be 
addressed, including safety, conversion efficiency and 
epigenetic memory [1, 2]. 
Astrocytes are considered to be the ideal starting 
candidate cell type for generating new neurons, due to 
their proximity in lineage distance to neurons and abili-
ty to proliferate after brain damage. Many studies have 
already revealed that astrocytes of the central nervous 
system can be reprogrammed into induced neuronal cells 
by virus-mediated overexpression of specific TFs in vitro 
and in vivo [3-6]. However, application of this virus-me-
diated direct conversion is still limited due to concerns 
on clinical safety. We have previously reported direct 
conversion of somatic cells into neural progenitor cells 
(NPCs) in vitro by cocktail of small molecules under hy-
poxia [7]. Here we set out to explore whether astrocytes 
can be induced into neuronal cells by the chemical cock-
tail in vitro. 
We first isolated astrocytes from 1-day postnatal 
mouse brain. To exclude contamination of neuronal cells 
and NPCs in primary astrocytes, we strictly followed the 
isolation protocol and used cells passaged at least three 
times in each experiment. Moreover, retrovirus-medi-
ated delivery of GFAP::GFP reporters into these cells, 
which selectively label proliferative astrocytes, but not 
neuronal cells, further confirmed the purity of astrocytes 
(Supplementary information, Figure S1A-S1D) [3]. Then 
we treated cultured astrocytes with the chemical cocktail 
VCR (V, VPA, 3 mM; C, CHIR99021, 3 μM; R, Rep-
sox, 1 μM). The same cocktail reported in our previous 
study [7] was used here with slight modification, such 
as the optimized VPA concentration. Briefly, astrocytes 
cultured in astrocyte medium for 48 h were transferred 
into DMEM/F12 medium that contains the VCR cock-
tail and other supplements including B27, N2, 20 ng/ml 
BDNF and 20 ng/ml GDNF. The VCR-containing medi-
um was changed every 4 days. After 8 days under VCR 
treatment, cells were maintained in DMEM/F12 medium 
(containing 400 ng/ml shh, 100 ng/ml FGF8, 10 ng/ml 
bFGF, 20 μM L-Ascorbic acid, 20 ng/ml BDNF, 20 ng/
ml GDNF, B27 and N2) without the cocktail under hy-
poxia. Astrocytes were added to fill the blank and support 
the development of induced neuronal cells when neces-
sary. Obviously, VCR treatment changed the cell mor-
phology from astrocyte- into neuronal cell-like morphol-
ogy, as shown by the phase contrast images (Figure 1A). 
Importantly, cultured mouse astrocytes can be induced 
into DCX+ neuroblasts (Figure 1B) and Tuj1+ or NeuN+ 
neurons  (Figure 1C) 12 days and 18 days post induction, 
respectively. Quantification of conversion efficiency 
showed that DCX+ cells appeared as early as 3 days post 
induction, and the number of DCX+ cells peaked on day 
12 and then slightly decreased. In contrast, NeuN+ cells 
were detectable from day 6 and their number gradually 
increased afterwards (Supplementary information, Figure 
S1E). The dynamic alteration in expression of neuronal 
cell markers in a continuous process reinforces the idea 
that induced neuronal cells are generated from starting 
astrocytes. Importantly, we observed that mature neurons 
induced from cultured astrocytes fired repetitive trains 
of action potentials and exhibited postsynaptic current 
spontaneously (Figure 1D-1F). During the whole conver-
sion process from astrocytes to neuronal cells, we did not 
observe emergence of Sox2+ NPCs (Supplementary in-
formation, Figure S2A and S2B). Moreover, NPCs were 
also absent even when astrocytes were cultured under the 
same condition used for NPC induction from fibroblasts 
[7].
To tease out critical constituent(s) enabling astrocyt-
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Figure 1 Cultured astrocytes are induced into neuronal cells by small molecules. (A) Cultured astrocytes showed neuronal 
morphology 12 days post VCR induction (DPI, days post induction). GFP+ cells stand for astrocytes labelled by GFAP::GFP. 
(B) Cultured astrocytes were converted into DCX+ neuoroblasts 12 days post VCR induction. (C) Neuronal cells converted from 
astrocytes expressed mature neuron markers Tuj1 and NeuN 18 days post VCR treatment. (D) Patch-clamp recording was 
conducted on VCR-induced neurons from cultured astrocytes identified by fluorescence 26 days post induction. (E) Current-clamp 
recordings of neurons derived from cultured astrocytes with VCR treatment showed a representative train of action potentials with 
stepwise current injection. (F) Representative traces of spontaneous postsynaptic currents recorded in VCR-induced neurons from 
astrocytes. (G) Proportion of GFP+ cells co-expressing DCX or NeuN in the final GFP+ cells. (H) Heat map depicting the relative fold 
changes of gene expression levels in astrocytes 1 week after chemical treatment in vitro. The value in the color bar indicates log2 
changes (relative to HPRT and normalized to ctrl). (I, J) DCX+, Tuj1+ and NeuN+ cells were generated from cultured astrocytes under 
treatment of the drug cocktail VT. Data are presented as mean ± SEM; scale bar, 10 μm.
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ic-to-neuronal transition within the chemical cocktail, we 
conducted screens by removing one or two component(s) 
from the cocktail. Elimination of VPA significantly 
abolished the generation of neuroblasts from astrocytes, 
whereas the exclusion of CHIR99021 or Repsox had 
minimal effect on neuroblast induction under our cultur-
ing conditions. Interestingly, conversion induced by VR 
(VPA and Repsox) was as efficient as that by the VCR 
cocktail. In contrast, VPA alone was able to induce as-
trocytes into neuroblasts with lower efficiency compared 
with VR, while neither CHIR99021 or Repsox alone 
nor their combination produced any induced neuroblasts 
(Supplementary information, Figure S1F and S1G). Later 
these chemical-induced neuroblasts developed into ma-
ture neurons expressing NeuN with diverse efficiencies 
(Supplementary information, Figure S1H). Calculation 
of DCX+ or NeuN+ cell proportion in the final population 
(Figure 1G) or conversion efficiency (neuronal mark-
er-positive cell number/initial cell number; Supplementa-
ry information, Figure S1I) at different time points clear-
ly demonstrates that the critical chemical components in 
VCR are VPA and Repsox. Mature neurons of specific 
types were also generated from astrocytes 25 days post 
VR induction, including dopaminergic neurons, GAB-
Aergic neurons, glutamatergic neurons and motor neu-
rons (Supplementary information, Figure S1J-S1N). The 
glycogen synthase kinase 3 inhibitor CHIR99021 has 
been reported to strongly enhance NeuroD1 expression 
in NPCs, which leads to neuronal differentiation from 
NPCs [8]. However, CHIR99021 did not activate Neu-
roD1 expression or facilitate neuronal conversion in our 
system, which also excludes the possibility of contam-
ination and generation of NPCs here. In addition, we 
did not find any chemical component in VCR or their 
combination  that contributed to proliferation of the start-
ing cells or neurons, further excluding the possibility of 
neuron contamination in starting cells (Supplementary 
information, Figure S2C-S2E). 
To analyze the potential underling mechanisms, we 
first checked the expression of TFs including NeuroG2, 
NeuroD1, Ascl1, Pax6, Dlx2 and Sox2, each of which 
has been reported to sufficiently reprogram astrocytes 
into neuronal cells [9]. Surprisingly, no chemical or 
chemical cocktail was able to activate Ascl1, Dlx2, Sox2 
and Pax6 expression. Cocktails containing VPA or even 
VPA alone could significantly activate the expression of 
NeuroG2 and NeuroD1 (Figure 1H). Among these two 
TFs, NeuroD1-induced astrocytic-to-neural conversion 
was also confirmed in our system (Supplementary infor-
mation, Figure S2F and S2G). These two TFs contain the 
basic helix-loop-helix (bHLH) DNA-binding domain. 
Since Notch signaling regulates bHLH factors as a con-
served module and also regulates neurogenic program of 
astrocytes after brain stroke [10], we next investigated 
the expression pattern of genes involved in this pathway. 
However, treatment with the chemical(s) did not cause 
any significant change in the expression of Notch recep-
tors 1/2/3/4 and Notch ligands Dll1/3/4, Jagged1/2 and 
Hes1/5 (Supplementary information, Figure S2H and Ta-
ble S1). Based on these findings, we suggest that chemi-
cals capable of inducing astrocytic-to-neuronal transition 
might act by inducing NeuroG2 and NeuroD1 expression 
independently of Notch signaling. 
Our previous study showed that components of chemi-
cal cocktails capable of inducing cell reprogramming can 
be substituted with other small molecules targeting the 
same signaling pathway [7]. Thus, we wonder whether it 
is possible to replace chemicals in the cocktail with phar-
maceutical compounds, which might be directly applied 
in vivo for translational medicine. The reduced-chemical 
cocktail VR contains VPA and Repsox that can inhibit 
histone deacetylases and TGF-β signaling, respectively. 
We kept VPA (an anticonvulsant and mood-stabilizing 
drug), replaced Repsox by another TGF-β inhibitor Tra-
nilast (T, an antiallergic drug, 100 μM), and then tested 
the neuronal induction capacity of this new drug cocktail 
(termed as VT). As expected, DCX+ cells were generated 
from cultured astrocytes 12 days post induction using VT 
(Figure 1I). Neurons expressing Tuj1 or NeuN were also 
observed 18 days post induction (Figure 1J). Consistent-
ly, VT also significantly activated expression of NeuroG2 
and NeuroD1 in astrocytes under the conversion condi-
tions (Supplementary information, Figure S2I).
In summary, our results demonstrate that small mol-
ecules can directly convert astrocytes into neurons in 
vitro through activation of NeuroG2 and NeuroD1 ex-
pression. Using small molecules to manipulate this cell 
fate transition can be an attractive approach for clinical 
application. Importantly, we also found that the chemi-
cal cocktail VCR can enable astrocytes of adult mice to 
acquire neuronal cell properties in vitro (Supplementary 
information, Figure S2J-S2L), suggesting the practical 
implication of such chemical-induced conversion in vivo. 
The potential effects of these chemicals on other types 
of cells, such as neurons, need to be systematically and 
carefully evaluated in the future. Nevertheless, local de-
livery of small molecules or systematic administration of 
drug cocktail enabling astrocytic-to-neuronal conversion 
might achieve direct induction of desirable cells from 
resident astrocytes in situ to meet the ultimate goal of re-
generative medicine. 
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